1. Home
  2. |Insights
  3. |Fraudulent Claim Gets The Triple Whammy

Fraudulent Claim Gets The Triple Whammy

Client Alert | less than 1 min read | 03.03.09

In Daewoo Eng'g and Constr. Co. v. U.S. (Fed. Cir. Feb. 20, 2009), the Federal Circuit affirmed the CFC's findings that the contractor had submitted a $64 million claim involving approximately $50 million based on material misrepresentations that amounted to a fraud. From this, the contractor received the triple whammy of forfeiting its entire claim under the CDA, being penalized $50 million under the CDA, and being fined $10,000 under the FCA.

Insights

Client Alert | 3 min read | 03.02.26

Changes to UK Clinical Trials Regulations Take Effect April 28, 2026. New Versions of UK Model Clinical Trial Agreement Forms Pending.

Clinical trial sponsors and all other stakeholders involved in conducting commercial clinical trials of investigational medicinal products (IMP) in the UK....